Filing Details

Accession Number:
0000899243-21-026555
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-29 16:15:58
Reporting Period:
2021-06-28
Accepted Time:
2021-06-29 16:15:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680581 Fulcrum Therapeutics Inc. FULC Pharmaceutical Preparations (2834) 474839948
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1779120 G. Peter Thomson C/O Fulcrum Therapeutics, Inc.
26 Landsdowne Street
Cambridge MA 02139
Vp Finance & Accounting No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-28 2,300 $9.00 2,300 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. Held by the Reporting Person's child.